{"id":7679,"date":"2024-08-28T13:47:53","date_gmt":"2024-08-28T12:47:53","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=7679"},"modified":"2024-08-28T13:47:53","modified_gmt":"2024-08-28T12:47:53","slug":"infarmed-atualiza-precos-grupos-homogeneos","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/","title":{"rendered":"INFARMED altera pre\u00e7os com novos grupos homog\u00e9neos"},"content":{"rendered":"<\/p>\n<p style=\"text-align: center;\"><strong>INFARMED altera pre\u00e7os com novos grupos homog\u00e9neos<\/strong><\/p>\n<p style=\"text-align: center;\">O INFARMED atualizou a lista de Grupos Homog\u00e9neos e os pre\u00e7os de refer\u00eancia unit\u00e1rios para o 3.\u00ba trimestre de 2024 no \u00e2mbito do Sistema de Pre\u00e7os de Refer\u00eancia. A nova lista define os valores que vigorar\u00e3o no mercado durante este per\u00edodo. O INFARMED garante a acessibilidade e o controlo de custos dos medicamentos com essas atualiza\u00e7\u00f5es. <a href=\"https:\/\/www.infarmed.pt\/web\/infarmed\/noticias\/-\/journal_content\/56\/15786\/10156604\" target=\"_blank\" rel=\"noopener\">Leia mais aqui<\/a><\/p>\n<p style=\"text-align: center;\">Se precisar de mais informa\u00e7\u00f5es sobre quest\u00f5es regulat\u00f3rias, a ELS pode certamente ajudar.<\/p>\n<p style=\"text-align: center;\"><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Por favor entre em contato com o seu <a href=\"https:\/\/els-solutions.com\/onde-estamos\/\" target=\"_blank\" rel=\"noopener\">consultor local da ELS<\/a> <\/span><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">ou atrav\u00e9s do email: info@elssolutions.pt<\/span><\/p>\n<p>\n","protected":false},"excerpt":{"rendered":"<p>INFARMED atualiza lista de Grupos Homog\u00e9neos e pre\u00e7os para o 3.\u00ba trimestre de 2024, garantindo acessibilidade.<\/p>\n","protected":false},"author":9,"featured_media":7681,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53,60],"tags":[64],"class_list":["post-7679","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-geral","category-noticias","tag-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>INFARMED atualiza pre\u00e7os com novos grupos homog\u00e9neos<\/title>\n<meta name=\"description\" content=\"INFARMED atualiza lista de Grupos Homog\u00e9neos e pre\u00e7os para o 3.\u00ba trimestre de 2024, garantindo acessibilidade.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INFARMED atualiza pre\u00e7os com novos grupos homog\u00e9neos\" \/>\n<meta property=\"og:description\" content=\"INFARMED atualiza lista de Grupos Homog\u00e9neos e pre\u00e7os para o 3.\u00ba trimestre de 2024, garantindo acessibilidade.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-28T12:47:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"INFARMED altera pre\u00e7os com novos grupos homog\u00e9neos\",\"datePublished\":\"2024-08-28T12:47:53+00:00\",\"dateModified\":\"2024-08-28T12:47:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/\"},\"wordCount\":1060,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg\",\"keywords\":[\"Not\u00edcias\"],\"articleSection\":[\"Geral\",\"Not\u00edcias\"],\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/\",\"name\":\"INFARMED atualiza pre\u00e7os com novos grupos homog\u00e9neos\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg\",\"datePublished\":\"2024-08-28T12:47:53+00:00\",\"dateModified\":\"2024-08-28T12:47:53+00:00\",\"description\":\"INFARMED atualiza lista de Grupos Homog\u00e9neos e pre\u00e7os para o 3.\u00ba trimestre de 2024, garantindo acessibilidade.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg\",\"width\":1200,\"height\":600,\"caption\":\"Medicamentos Grupos Homog\u00e9neos\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/pt-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INFARMED altera pre\u00e7os com novos grupos homog\u00e9neos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#website\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/pt-pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INFARMED atualiza pre\u00e7os com novos grupos homog\u00e9neos","description":"INFARMED atualiza lista de Grupos Homog\u00e9neos e pre\u00e7os para o 3.\u00ba trimestre de 2024, garantindo acessibilidade.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"pt_PT","og_type":"article","og_title":"INFARMED atualiza pre\u00e7os com novos grupos homog\u00e9neos","og_description":"INFARMED atualiza lista de Grupos Homog\u00e9neos e pre\u00e7os para o 3.\u00ba trimestre de 2024, garantindo acessibilidade.","og_url":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2024-08-28T12:47:53+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg","type":"image\/jpeg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Marketing ELS","Tempo estimado de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"INFARMED altera pre\u00e7os com novos grupos homog\u00e9neos","datePublished":"2024-08-28T12:47:53+00:00","dateModified":"2024-08-28T12:47:53+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/"},"wordCount":1060,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg","keywords":["Not\u00edcias"],"articleSection":["Geral","Not\u00edcias"],"inLanguage":"pt-PT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/","url":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/","name":"INFARMED atualiza pre\u00e7os com novos grupos homog\u00e9neos","isPartOf":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg","datePublished":"2024-08-28T12:47:53+00:00","dateModified":"2024-08-28T12:47:53+00:00","description":"INFARMED atualiza lista de Grupos Homog\u00e9neos e pre\u00e7os para o 3.\u00ba trimestre de 2024, garantindo acessibilidade.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/08\/ELS-Solutions-reference-price-system-1.jpg","width":1200,"height":600,"caption":"Medicamentos Grupos Homog\u00e9neos"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/pt-pt\/infarmed-atualiza-precos-grupos-homogeneos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"INFARMED altera pre\u00e7os com novos grupos homog\u00e9neos"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/pt-pt\/#website","url":"https:\/\/els-solutions.com\/pt-pt\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/pt-pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/pt-pt\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/pt-pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=7679"}],"version-history":[{"count":1,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7679\/revisions"}],"predecessor-version":[{"id":7684,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/7679\/revisions\/7684"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/media\/7681"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=7679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/categories?post=7679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=7679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}